TABLE 3.
Number of Subjects Needed in Each Groupa to Detect a Stabilization of Disease Progression b With 80% Power
VL FF | 6MWT | |
---|---|---|
All ImagingDMD subjects | 13 | 68 |
5.0–6.9 years | 44 | 783 |
7.0–8.9 years | 9 | 83 |
9.0–10.9 years | 5 | 27 |
11.0–12.9 years | 17 | 44 |
Treated and untreated.
No change over 1 year in treated group; change in untreated group based on the data presented in Table 2. 6MWT=6-minute walk test; DMD=Duchenne muscular dystrophy; FF=fat fraction; VL=vastus lateralis.